Key Highlights
- Lisa Wolf appointed as Interim CFO of Tivic Health, effective October 1, 2024.
- Kimberly Bambach to transition into an advisory role, focusing on strategic transactions.
- Wolf brings 30 years of financial leadership and over two years with Tivic Health.
- Tivic Health continues growth in bioelectronic medicine with experienced leadership.
Source: Business Wire
Notable Quote
- “Lisa has served as a senior member of Tivic’s finance team for over two years, and I am delighted to have her taking on an even more pivotal role. I am also deeply grateful for Kimberly Bambach’s contributions over the past 18 months as we restructured the company to better address current and future market opportunities.” — Jennifer Ernst, CEO at Tivic Health
SoHC's Take
Tivic Health’s appointment of Lisa Wolf as Interim CFO signals a strategic move toward continued financial stability and operational growth. With Wolf’s extensive experience and deep knowledge of the company, Tivic is well-positioned to advance its bioelectronic medicine initiatives. The retention of Kimberly Bambach in an advisory role ensures that Tivic retains critical expertise during this transition, further strengthening the company’s approach to future strategic transactions. This decision reflects a thoughtful alignment of leadership to support Tivic’s long-term objectives in a competitive health tech landscape.
Heading
Key Highlights Ginkgo Bioworks releases first proprietary protein LLM, trained on exclusive datasets.Collaboration with Google Cloud enables AI-driven drug discovery tools.Open API allows researchers to access Ginkgo’s machine ...
Key Highlights Courtney Green joins QGenda as Vice President of Nurse and Staff Solutions.Brings over 20 years of clinical and operational leadership experience.Focus on optimizing ...
Key Highlights Vyne Medical® acquires Extract Systems®, a leader in data extraction solutions.Accelerates healthcare automation by integrating AI and machine learning ...
Key Highlights PatientPay integrates with Azalea Health’s API to streamline patient billing for ambulatory providers.Faster revenue capture with less than 14 days to payment, ...
Key Highlights Partnership streamlines revenue cycle management for ABA therapy providers.Flychain’s financial tools offer real-time insights, secure funding, and automation.Raven ...
Key Highlights Nura Bio closes $140M Series A financing to support clinical development.Shilpa Sambashivan, Ph.D., appointed as CEO following Phase 1 success ...
